{"id":"SCV000187678","clinical_assertion_trait_set_id":"SCV000187678","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}}}","submission_id":"505267.2014-07-16","version":"1","internal_id":"339358","clinical_assertion_observation_ids":["SCV000187678.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"6607","date_created":"2014-11-11","submitter_id":"505267","rcv_accession_id":"RCV000144921","submission_names":[],"local_key":"rs1801133","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000884146","clinical_assertion_trait_set_id":"SCV000884146","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2018-07-13","version":"2","internal_id":"1730401","clinical_assertion_observation_ids":["SCV000884146.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2019-02-15","submitter_id":"25969","rcv_accession_id":"RCV000428048","submission_names":["Aug 2019 ARUP"],"local_key":"74380|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000268236","clinical_assertion_trait_set_id":"SCV000268236","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981204929\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20638924\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2016-07-11","version":"3","internal_id":"503703","clinical_assertion_observation_ids":["SCV000268236.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"26869","date_created":"2016-05-18","submitter_id":"500295","rcv_accession_id":"RCV000211133","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"981204929PA449165|cyclophosphamide response - Toxicity/ADR","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000268238","clinical_assertion_trait_set_id":"SCV000268238","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981220481\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19307503\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21605004\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2016-07-11","version":"3","internal_id":"503705","clinical_assertion_observation_ids":["SCV000268238.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"26870","date_created":"2016-05-18","submitter_id":"500295","rcv_accession_id":"RCV000211336","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"981220481PA448803|carboplatin response - Efficacy","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000891532","clinical_assertion_trait_set_id":"SCV000891532","content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"16432849\",\"@Source\":\"PubMed\"}}}}","submission_id":"506653.2018-10-25","interpretation_date_last_evaluated":"2017-12-30","version":"1","internal_id":"1747332","clinical_assertion_observation_ids":["SCV000891532.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"6404","date_created":"2019-03-21","submitter_id":"506653","rcv_accession_id":"RCV000761447","submission_names":["SUB4684823"],"local_key":"NM_005957.4:c.665C\u003eT|OMIM:188050","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000494694","clinical_assertion_trait_set_id":"SCV000494694","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/827848365\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"11418485\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12453860\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12915598\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14647408\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15781665\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16013960\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16019535\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16462575\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16463153\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16501586\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16870553\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17180579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17323057\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17488658\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17512587\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18458567\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18987660\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19648163\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21644011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21747412\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22143415\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22838948\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23089671\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23488607\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23648444\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23775025\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24241962\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24637499\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25007187\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25065700\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25110820\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25303299\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25778468\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26014925\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27399166\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28696419\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29683944\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2018-05-14","version":"2","internal_id":"967913","clinical_assertion_observation_ids":["SCV000494694.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"35046","date_created":"2017-02-17","submitter_id":"500295","rcv_accession_id":"RCV000417131","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"827848365PA450428|methotrexate response - Dosage, Efficacy, Toxicity/ADR","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000505736","clinical_assertion_trait_set_id":"SCV000505736","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000376592:c.665C\u003eT\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"18704422\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-03-10","version":"1","internal_id":"971011","clinical_assertion_observation_ids":["SCV000505736.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion provided","trait_set_id":"6728","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000427078","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000376592:c.665C\u003eT|MeSH:D013274","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"not provided","variation_id":"3520"}
{"id":"SCV000519504","clinical_assertion_trait_set_id":"SCV000519504","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","interpretation_date_last_evaluated":"2016-04-25","version":"4","internal_id":"984917","clinical_assertion_observation_ids":["SCV000519504.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2017-03-03","submitter_id":"26957","rcv_accession_id":"RCV000428048","submission_names":["SUB3839901"],"local_key":"GDX:570299|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"record_status":"current","interpretation_description":"Benign","variation_id":"3520"}
{"id":"SCV000203040","clinical_assertion_trait_set_id":"SCV000203040","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MTHFR\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2017-01-13","version":"7","internal_id":"361011","clinical_assertion_observation_ids":["SCV000203040.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2015-01-28","submitter_id":"500060","rcv_accession_id":"RCV000153516","submission_names":["SUB4534263"],"local_key":"8162_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"other","variation_id":"3520"}
{"id":"SCV001135171","clinical_assertion_trait_set_id":"SCV001135171","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","submission_id":"500035.2019-10-22","interpretation_date_last_evaluated":"2019-05-28","version":"1","internal_id":"2240970","clinical_assertion_observation_ids":["SCV001135171.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"6564","date_created":"2020-01-07","submitter_id":"500035","rcv_accession_id":"RCV000259890","submission_names":["MENDELICS_CLINVAR_020"],"local_key":"NC_000001.10:g.11856378G\u003eA|OMIM:601634","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"3520"}
{"id":"SCV001147149","clinical_assertion_trait_set_id":"SCV001147149","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","submission_id":"505870.2019-07-12","interpretation_date_last_evaluated":"2016-10-01","version":"1","internal_id":"2265337","clinical_assertion_observation_ids":["SCV001147149.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-30","submitter_id":"505870","rcv_accession_id":"RCV000153516","submission_names":["2019-07"],"local_key":":Chr.1_11856378_11856378_G_A|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000023860","clinical_assertion_trait_set_id":"SCV000023860","submission_id":"3.2015-03-10","interpretation_date_last_evaluated":"2019-06-11","version":"6","internal_id":"23860","clinical_assertion_observation_ids":["SCV000023860.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","title":"MTHFR, 677C-T, ALA222VAL (rs1801133)_MTHFR THERMOLABILE POLYMORPHISM","trait_set_id":"916","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000003697","submission_names":[],"local_key":"607093.0003_MTHFR THERMOLABILE POLYMORPHISM","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"3520"}
{"id":"SCV000106043","clinical_assertion_trait_set_id":"SCV000106043","submission_id":"256489.2017-03-08","version":"1","internal_id":"183447","clinical_assertion_observation_ids":["SCV000106043.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"916","date_created":"2013-11-19","submitter_id":"256489","rcv_accession_id":"RCV000003697","submission_names":["FirmaLab_clinical_tests_from_GTR"],"local_key":"NM_005957.4:c.665C\u003eT|MedGen:C1856059","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"3520"}
{"id":"SCV000347807","clinical_assertion_trait_set_id":"SCV000347807","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"661330","clinical_assertion_observation_ids":["SCV000347807.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"6564","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000259890","submission_names":["ICSL_2016Q4"],"local_key":"361|Neural Tube Defects, Folate-Sensitive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"3520"}
{"id":"SCV000549301","clinical_assertion_trait_set_id":"SCV000549301","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}","submission_id":"500031.2020-02-06","interpretation_date_last_evaluated":"2019-11-25","version":"6","internal_id":"1062197","clinical_assertion_observation_ids":["SCV000549301.0"],"date_last_updated":"2020-04-15","assertion_type":"variation to disease","variation_archive_id":"VCV000037594","review_status":"criteria provided, single submitter","trait_set_id":"7920","date_created":"2017-04-13","submitter_id":"500031","rcv_accession_id":"RCV000458634","submission_names":["SUB6933778"],"local_key":"676082|MedGen:C0677776","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"37594"}
{"id":"SCV001119032","clinical_assertion_trait_set_id":"SCV001119032","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2086965","clinical_assertion_observation_ids":["SCV001119032.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-14","submitter_id":"500031","rcv_accession_id":"RCV000727222","submission_names":["SUB6897608"],"local_key":"2035389|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"46503"}
{"id":"SCV001144884","clinical_assertion_trait_set_id":"SCV001144884","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27208204\",\"@Source\":\"PubMed\"}}}}","submission_id":"1012.2019-09-25","interpretation_date_last_evaluated":"2019-03-14","version":"1","internal_id":"2256633","clinical_assertion_observation_ids":["SCV001144884.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-16","submitter_id":"1012","rcv_accession_id":"RCV000727222","submission_names":["SUB6347501"],"local_key":"2853148|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV001157178","clinical_assertion_trait_set_id":"SCV001157178","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2019-06-26","version":"1","internal_id":"2281510","clinical_assertion_observation_ids":["SCV001157178.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2020-02-07","submitter_id":"25969","rcv_accession_id":"RCV000039762","submission_names":["Aug 2019 ARUP"],"local_key":"121670|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"46503"}
{"id":"SCV000063451","clinical_assertion_trait_set_id":"SCV000063451","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2017-09-04","version":"6","internal_id":"104651","clinical_assertion_observation_ids":["SCV000063451.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000039762","submission_names":["SUB5348979"],"local_key":"30968208|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located ne ar a splice junction and has been identified in 0.3% (381/126618) European chro mosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute .org; dbSNP rs111033445).\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV000706730","clinical_assertion_trait_set_id":"SCV000706730","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCDH15\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2018-05-30","version":"2","internal_id":"1379128","clinical_assertion_observation_ids":["SCV000706730.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-03-28","submitter_id":"500060","rcv_accession_id":"RCV000727222","submission_names":["SUB4534263"],"local_key":"60128_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV000729392","clinical_assertion_trait_set_id":"SCV000729392","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","interpretation_date_last_evaluated":"2017-11-21","version":"1","internal_id":"1410550","clinical_assertion_observation_ids":["SCV000729392.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2018-04-04","submitter_id":"26957","rcv_accession_id":"RCV000039762","submission_names":["SUB3839901"],"local_key":"GDX:46979|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV000363106","clinical_assertion_trait_set_id":"SCV000363106","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"676628","clinical_assertion_observation_ids":["SCV000363106.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"33370","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000326661","submission_names":["ICSL_2016Q4"],"local_key":"165026|Nonsyndromic Hearing Loss, Recessive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV000363107","clinical_assertion_trait_set_id":"SCV000363107","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"676629","clinical_assertion_observation_ids":["SCV000363107.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","date_created":"2016-12-02","submitter_id":"504895","submission_names":["ICSL_2016Q4"],"local_key":"165026|Usher Syndrome","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV001144806","clinical_assertion_trait_set_id":"SCV001144806","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20146813\",\"@Source\":\"PubMed\"}}]}}","submission_id":"1012.2019-09-25","interpretation_date_last_evaluated":"2019-05-14","version":"1","internal_id":"2256555","clinical_assertion_observation_ids":["SCV001144806.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-16","submitter_id":"1012","rcv_accession_id":"RCV000726979","submission_names":["SUB6347501"],"local_key":"2854484|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000065162","clinical_assertion_trait_set_id":"SCV000065162","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2018-08-21","version":"6","internal_id":"106362","clinical_assertion_observation_ids":["SCV000065162.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000041467","submission_names":["SUB5348979"],"local_key":"11832988|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosom al recessive sensorineural hearing loss who carried a second OTOF variant of unc ertain significance; it is unclear whether these variants are in trans (Sommen 2 016). The p.Arg544Cys variant has also been identified by our laboratory in 6 in dividuals with hearing loss; however, none of these individuals carried a varian t affecting the other copy of the OTOF gene or was reported to have auditory neu ropathy typically associated with OTOF related hearing loss. This variant has be en reported in ClinVar (Variation ID: 48176). It has been identified in 0.15% (1 93/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal ysis suggest that the p.Arg544Cys variant may impact the protein, though this in formation is not predictive enough to determine pathogenicity. In summary, the c linical significance of the p.Arg544Cys variant is uncertain. ACMG/AMP Criteria applied: PP3, BS1_Supporting.\"}"],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000704632","clinical_assertion_trait_set_id":"SCV000704632","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OTOF\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2016-12-20","version":"2","internal_id":"1377031","clinical_assertion_observation_ids":["SCV000704632.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-03-28","submitter_id":"500060","rcv_accession_id":"RCV000726979","submission_names":["SUB4534263"],"local_key":"57851_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000429634","clinical_assertion_trait_set_id":"SCV000429634","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"743155","clinical_assertion_observation_ids":["SCV000429634.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"33370","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000357820","submission_names":["ICSL_2016Q4"],"local_key":"231996|Nonsyndromic Hearing Loss, Recessive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV001037250","clinical_assertion_trait_set_id":"SCV001037250","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2005121","clinical_assertion_observation_ids":["SCV001037250.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000007884","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-11","submitter_id":"500031","rcv_accession_id":"RCV000078671","submission_names":["SUB6897608"],"local_key":"2281434|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"7884"}
{"id":"SCV000504294","clinical_assertion_trait_set_id":"SCV000504294","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969570","clinical_assertion_observation_ids":["SCV000504294.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"11864","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000443065","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D001932","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504300","clinical_assertion_trait_set_id":"SCV000504300","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969576","clinical_assertion_observation_ids":["SCV000504300.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"9305","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000418680","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D015451","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504293","clinical_assertion_trait_set_id":"SCV000504293","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969569","clinical_assertion_observation_ids":["SCV000504293.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"35132","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000433779","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D018268","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504295","clinical_assertion_trait_set_id":"SCV000504295","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14679157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18794803\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12068308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25157968\",\"@Source\":\"PubMed\"}}]},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2015-07-14","version":"1","internal_id":"969571","clinical_assertion_observation_ids":["SCV000504295.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"12074","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000426339","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D008545","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000504299","clinical_assertion_trait_set_id":"SCV000504299","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969575","clinical_assertion_observation_ids":["SCV000504299.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"1717","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000435875","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C535575","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504298","clinical_assertion_trait_set_id":"SCV000504298","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969574","clinical_assertion_observation_ids":["SCV000504298.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"3349","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000426107","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C538231","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504296","clinical_assertion_trait_set_id":"SCV000504296","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969572","clinical_assertion_observation_ids":["SCV000504296.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"35142","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000437006","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MedGen:C0279680","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504291","clinical_assertion_trait_set_id":"SCV000504291","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19537845\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22310681\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12068308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25157968\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20619739\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21129611\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20350999\",\"@Source\":\"PubMed\"}}]},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969567","clinical_assertion_observation_ids":["SCV000504291.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"31428","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000443882","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D015179","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000504292","clinical_assertion_trait_set_id":"SCV000504292","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969568","clinical_assertion_observation_ids":["SCV000504292.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"6369","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000423919","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:C562393","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000504297","clinical_assertion_trait_set_id":"SCV000504297","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000288602:c.1781A\u003eG\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"26619011\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-05-31","version":"1","internal_id":"969573","clinical_assertion_observation_ids":["SCV000504297.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","trait_set_id":"6478","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000442759","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000288602:c.1781A\u003eG|MeSH:D009101","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"13972"}
{"id":"SCV000035262","clinical_assertion_trait_set_id":"SCV000035262","submission_id":"3.2010-12-30","interpretation_date_last_evaluated":"2003-11-17","version":"6","internal_id":"35262","clinical_assertion_observation_ids":["SCV000035262.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"no assertion criteria provided","title":"BRAF, ASP594GLY_LYMPHOMA, NON-HODGKIN, SOMATIC","trait_set_id":"3352","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000015006","submission_names":[],"local_key":"164757.0011_LYMPHOMA, NON-HODGKIN, SOMATIC","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000061597","clinical_assertion_trait_set_id":"SCV000061597","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"14688025\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2012-06-11","version":"4","internal_id":"102797","clinical_assertion_observation_ids":["SCV000061597.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000013972","review_status":"criteria provided, single submitter","trait_set_id":"4069","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000037932","submission_names":["SUB5348977"],"local_key":"15072993|MeSH:D002289","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant has been reported as a somatic change in large intestine, skin, end ometrium, stomach, and ovary (COSMIC, Fransen 2004) and has been observed in up to 11% of BRAF mutant positive lung adenocarcinoma (Paik 2011).\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"13972"}
{"id":"SCV000883121","clinical_assertion_trait_set_id":"SCV000883121","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"506039.2018-11-26","interpretation_date_last_evaluated":"2018-11-21","version":"1","internal_id":"1729239","clinical_assertion_observation_ids":["SCV000883121.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2019-02-15","submitter_id":"506039","rcv_accession_id":"RCV000020088","submission_names":["SUB4842992"],"local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000602533","clinical_assertion_trait_set_id":"SCV000602533","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2018-10-10","interpretation_date_last_evaluated":"2018-06-20","version":"2","internal_id":"1166229","clinical_assertion_observation_ids":["SCV000602533.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-09-27","submitter_id":"25969","rcv_accession_id":"RCV000034388","submission_names":["SUB4618058"],"local_key":"11931|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"822"}
{"id":"SCV000600091","clinical_assertion_trait_set_id":"SCV000600091","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29478780\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16875934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29506128\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30487145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12533824\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135136\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500110.2020-03-06","interpretation_date_last_evaluated":"2019-08-04","version":"2","internal_id":"1163765","clinical_assertion_observation_ids":["SCV000600091.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-09-27","submitter_id":"500110","rcv_accession_id":"RCV000034388","submission_names":["SUB6975398"],"local_key":"2564206|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000610138","clinical_assertion_trait_set_id":"SCV000610138","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"505698.2017-10-05","interpretation_date_last_evaluated":"2017-07-27","version":"1","internal_id":"1190191","clinical_assertion_observation_ids":["SCV000610138.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2017-11-02","submitter_id":"505698","rcv_accession_id":"RCV000034388","submission_names":[],"local_key":"19388615","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000148996","clinical_assertion_trait_set_id":"SCV000148996","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification(06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-09-07","interpretation_date_last_evaluated":"2015-05-08","version":"4","internal_id":"269650","clinical_assertion_observation_ids":["SCV000148996.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2014-05-13","submitter_id":"26957","rcv_accession_id":"RCV000034388","submission_names":["SUB4498316"],"local_key":"GDX:3786|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000153895","clinical_assertion_trait_set_id":"SCV000153895","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500031.2019-03-28","interpretation_date_last_evaluated":"2019-01-14","version":"9","internal_id":"279290","clinical_assertion_observation_ids":["SCV000153895.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2014-06-03","submitter_id":"500031","rcv_accession_id":"RCV000020088","submission_names":["SUB5371970"],"local_key":"7840|MedGen:C2713442","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces isoleucine with lysine at codon 1307 of the APC protein (p.Ile1307Lys). The isoleucine residue is weakly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is present in population databases (rs1801155, ExAC 0.3%). This variant is found in ~10% of Ashkenazi Jewish individuals and ~3% of Sephardic Jewish individuals (PMID: 23896379). Other studies have reported a 6-7% frequency in Ashkenazi individuals (PMID: 9288102). This variant is found in ~28% of Ashkenazi Jewish individuals with familial colorectal cancer (PMID: 9288102). ClinVar contains an entry for this variant (Variation ID: 822). In a large meta-analysis involving ~10,000 cases and controls (PMID: 23576677), Ashkenazi Jewish individuals who carried the I1307K change had a significantly increased risk of colorectal cancer (OR=2.17, 95% CI=1.65-2.86). By contrast, the I1307K change did not appear to confer any additional risk of colorectal cancer in non-Ashkenazi Jewish individuals (OR=1.36, 95% CI=0.59-3.13). This DNA substitution converts an AAATAAAA sequence element into an extended tract of eight adenosine nucleotides (A8). The A8 mononucleotide tract created by this change has been shown to confer an increased propensity for somatic truncating mutations on this allele (PMID: 9751605). In summary, this is a frequently observed variant that is associated with a 2-fold increased risk of colorectal cancer in the Ashkenazi Jewish population. An increased risk of colorectal cancer in individuals who are not of Ashkenazi Jewish ancestry has not been established.\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000084184","clinical_assertion_trait_set_id":"SCV000084184","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},\"Comment\":{\"$\":\"Please see associated publication for description of ethnicities\"}}","submission_id":"504914.2014-05-29","interpretation_date_last_evaluated":"2013-09-19","version":"1","internal_id":"281153","clinical_assertion_observation_ids":["SCV000084184.0","SCV000084184.1","SCV000084184.2","SCV000084184.3","SCV000084184.4","SCV000084184.5","SCV000084184.6"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion provided","trait_set_id":"9590","date_created":"2014-06-09","submitter_id":"504914","rcv_accession_id":"RCV000120049","submission_names":["Cancer_genes_01"],"local_key":"MedGen:CN169374","interpretation_comments":[],"record_status":"current","interpretation_description":"not provided","variation_id":"822"}
{"id":"SCV000297021","clinical_assertion_trait_set_id":"SCV000297021","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"DGD Variant Analysis Guidelines\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"DGD_Variant_Analysis_Guidelines.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx\"}}},\"StudyDescription\":{\"$\":\"Clinical exome data\"}}","submission_id":"165021.2016-01-06","interpretation_date_last_evaluated":"2015-11-24","version":"2","internal_id":"574598","clinical_assertion_observation_ids":["SCV000297021.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"8942","date_created":"2016-07-29","submitter_id":"165021","rcv_accession_id":"RCV000238802","submission_names":["exome2015-12-22"],"local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0032580","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV001154466","clinical_assertion_trait_set_id":"SCV001154466","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","submission_id":"505870.2019-07-12","interpretation_date_last_evaluated":"2019-05-01","version":"1","internal_id":"2272833","clinical_assertion_observation_ids":["SCV001154466.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-31","submitter_id":"505870","rcv_accession_id":"RCV000034388","submission_names":["2019-07"],"local_key":":Chr.5_112175211_112175211_T_A|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000805404","clinical_assertion_trait_set_id":"SCV000805404","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"239772.2018-01-29","interpretation_date_last_evaluated":"2016-01-06","version":"1","internal_id":"1570355","clinical_assertion_observation_ids":["SCV000805404.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-09-12","submitter_id":"239772","rcv_accession_id":"RCV000034388","submission_names":["SUB3589995"],"local_key":"NM_000038.5:c.3920T\u003eA|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000677724","clinical_assertion_trait_set_id":"SCV000677724","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_%25282015%2529_v1.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17854661\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15712637\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}}]}}","submission_id":"320494.2017-06-22","interpretation_date_last_evaluated":"2016-09-27","version":"1","internal_id":"1328882","clinical_assertion_observation_ids":["SCV000677724.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2018-01-04","submitter_id":"320494","rcv_accession_id":"RCV000020088","submission_names":["SUB2805501"],"local_key":"76464|OMIM:175100","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"I1307K is associated with a 10-20% lifetime risk of developing colon cancer in individuals of Ashkenazi Jewish ancestry and is not known to cause classic or attenuated FAP.\"}"],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"822"}
{"id":"SCV000807826","clinical_assertion_trait_set_id":"SCV000807826","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"1024.2018-07-17","interpretation_date_last_evaluated":"2018-06-01","version":"1","internal_id":"1575248","clinical_assertion_observation_ids":["SCV000807826.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"35108","date_created":"2018-09-20","submitter_id":"1024","rcv_accession_id":"RCV000680453","submission_names":["SUB4304907"],"local_key":"APC-B1|MedGen:CN240755","submitted_assembly":"GRCh38","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000838110","clinical_assertion_trait_set_id":"SCV000838110","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","submission_id":"500035.2018-11-11","interpretation_date_last_evaluated":"2018-07-02","version":"2","internal_id":"1610680","clinical_assertion_observation_ids":["SCV000838110.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2018-10-05","submitter_id":"500035","rcv_accession_id":"RCV000020088","submission_names":["MENDELICS_CLINVAR_015"],"local_key":"NC_000005.9:g.112175211T\u003eA|MedGen:C2713442","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"822"}
{"id":"SCV000821694","clinical_assertion_trait_set_id":"SCV000821694","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"505504.2020-03-06","interpretation_date_last_evaluated":"2020-01-01","version":"2","internal_id":"1609757","clinical_assertion_observation_ids":["SCV000821694.0"],"date_last_updated":"2020-04-22","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"13598","date_created":"2018-10-05","submitter_id":"505504","rcv_accession_id":"RCV000115087","submission_names":["SUB6775616"],"local_key":"NM_000038.5:c.3920T\u003eA|MedGen:C0027672","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces Isoleucine with Lysine at codon 1307 of the APC protein. The isoleucine residue is mildly conserved among species and is located in a known functional domain of the protein. There is a big physiochemical difference between isoleucine and lysine (Grantham Score 102). This variant is listed in population databases (rs1801155, ExAC 0.3) and is a common finding in individuals of Ashkenazi (~6-10%) and Sephardic Jewish decent (~3%; PMID: 9288102 ,23896379 ).Multiple studies have associated this variant with a moderate increase in the risk of colorectal cancer in individuals of Ashkenazi Jewish ancestry, in whom this variant is identified in 28% of cases with familial colorectal cancer (PMID: 9288102 ). In a recent meta-analysis the risk of colorectal cancer development was estimated to be increased 2-fold in Ashkenazi Jewish individuals carrying this variant, while this increase was not evident in other populations (PMID: 23576677). The mutation database ClinVar contains multiple entries for this variant (Variation ID:822).\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000021015","clinical_assertion_trait_set_id":"SCV000021015","submission_id":"3.2010-12-30","interpretation_date_last_evaluated":"2003-12-01","version":"3","internal_id":"21015","clinical_assertion_observation_ids":["SCV000021015.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to included disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","title":"APC, ILE1307LYS_BREAST CANCER, SUSCEPTIBILITY TO","trait_set_id":"216","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000000865","submission_names":[],"local_key":"611731.0029_BREAST CANCER, SUSCEPTIBILITY TO","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000021014","clinical_assertion_trait_set_id":"SCV000021014","submission_id":"3.2014-02-19","interpretation_date_last_evaluated":"2019-04-01","version":"3","internal_id":"21014","clinical_assertion_observation_ids":["SCV000021014.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","title":"APC, ILE1307LYS_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","trait_set_id":"215","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000000864","submission_names":[],"local_key":"611731.0029_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000839876","clinical_assertion_trait_set_id":"SCV000839876","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"500199.2018-06-14","interpretation_date_last_evaluated":"2017-06-02","version":"1","internal_id":"1637429","clinical_assertion_observation_ids":["SCV000839876.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"6265","date_created":"2018-10-11","submitter_id":"500199","rcv_accession_id":"RCV000020088","submission_names":["SUB4151980"],"local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The c.3920T\u003eA (p.Ile1307Lys) variant in the APC gene has been reported as a common risk allele associated with familial colorectal cancer in the Ashkenazi Jewish population [PMID 18770064, 24416237]. The c.3920T\u003eA variant has been reported to result in an adenine replacing a thymine and creating an oligo-adenine (A8) tract that appears to be inherently prone to further somatic mis-pairing and slippage during DNA replication, thereby creating a frameshift change [PMID 9288102, 18770064 and 244162370]. However, this variant has also been reported at a high frequency, present in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of colorectal cancer [PMID: 9288102]. Isoleucine at amino acid position 1307 of the APC protein is weakly conserved during evolution. While not validated for clinical use, the SIFT and PolyPhen-2 algorithms predict this variant to be benign. Ashkenazi Jews who carry the p.Ile1307Lys variant are at increased risk for colorectal neoplasia: the risk for colorectal neoplasia in heterozygous Ashkenazi Jewish individuals was estimated to be between 1.7 to 2.17 compared to non carrier individuals [PMID 12173321, 23576677, 23896379]. This variant is classified as as a risk allele with an increased risk for colorectal neoplasia in the Ashkenazi Jewish population. However the risk in non Jewish populations has not been determined.\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000183892","clinical_assertion_trait_set_id":"SCV000183892","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16228836\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}}]}}","submission_id":"61756.2020-02-26","interpretation_date_last_evaluated":"2019-02-28","version":"7","internal_id":"302407","clinical_assertion_observation_ids":["SCV000183892.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"13598","date_created":"2014-08-01","submitter_id":"61756","rcv_accession_id":"RCV000115087","submission_names":["NonExomeUpdate_101019AmbryReport"],"local_key":"a4793","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Significant disease association in appropriately sized case-control study(ies);Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Other strong data supporting pathogenic classification\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"822"}
{"id":"SCV000686956","clinical_assertion_trait_set_id":"SCV000686956","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"505849.2018-11-06","interpretation_date_last_evaluated":"2018-05-21","version":"2","internal_id":"1344252","clinical_assertion_observation_ids":["SCV000686956.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"13598","date_created":"2018-02-16","submitter_id":"505849","rcv_accession_id":"RCV000115087","submission_names":["SUB4721021"],"local_key":"Db4KrQBSZeoE7-orUyypkal4dklV7Tc_lQTp9W4PGUo|MedGen:C0027672","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely pathogenic","variation_id":"822"}
{"id":"SCV000043125","clinical_assertion_trait_set_id":"SCV000043125","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","submission_id":"1160.2012-07-15","interpretation_date_last_evaluated":"2012-07-13","version":"1","internal_id":"98286","clinical_assertion_observation_ids":["SCV000043125.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","trait_set_id":"9460","date_created":"2013-03-26","submitter_id":"1160","rcv_accession_id":"RCV000034388","submission_names":["ClinSeq_cancer"],"local_key":"NM_000038.4:c.3920T\u003eA|not provided","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\"}"],"record_status":"current","interpretation_description":"variant of unknown significance","variation_id":"822"}
{"id":"SCV000693480","clinical_assertion_trait_set_id":"SCV000693480","submission_id":"506273.2017-11-15","interpretation_date_last_evaluated":"2017-11-10","version":"1","internal_id":"1359177","clinical_assertion_observation_ids":["SCV000693480.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","trait_set_id":"13598","date_created":"2018-03-01","submitter_id":"506273","rcv_accession_id":"RCV000115087","submission_names":["SUB3222006"],"local_key":"CCDS4107.1:c.3920T\u003eA|Hereditary cancer-predisposing syndrome","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000853088","clinical_assertion_trait_set_id":"SCV000853088","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","submission_id":"506211.2018-10-29","interpretation_date_last_evaluated":"2017-01-01","version":"1","internal_id":"1663716","clinical_assertion_observation_ids":["SCV000853088.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"1735","date_created":"2018-11-21","submitter_id":"506211","rcv_accession_id":"RCV000722046","submission_names":["SUB4705375"],"local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0699790","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000694042","clinical_assertion_trait_set_id":"SCV000694042","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26300997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26394139\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27978560\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28050010\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25604157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10679643\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15929773\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11207040\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28749474\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30426508\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26187149\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500026.2019-09-24","interpretation_date_last_evaluated":"2019-08-27","version":"2","internal_id":"1360394","clinical_assertion_observation_ids":["SCV000694042.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2018-03-15","submitter_id":"500026","rcv_accession_id":"RCV000120049","submission_names":["SUB6341163"],"local_key":"NM_000038.5:c.3920T\u003eA|MedGen:CN169374","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: APC c.3920T\u003eA (p.Ile1307Lys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 251040 control chromosomes in the gnomAD database (exomes dataset), predominantly found within the Ashkenazi Jewish subpopulation at a frequency of 0.036, including 7 homozygotes. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 500 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis (FAP) phenotype (7.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Ashkenazi Jewish origin. The variant, c.3920T\u003eA, has been reported in the literature in multiple individuals affected with colorectal cancer (CRC) and other tumor phenotypes, however in some of these cases it was also reported to co-occur with other pathogenic variants (Yurgelun_2017 and Simbolo_2015). Multiple case-control studies (Abdel-Malak_2016, Drucker_2000, Fidder_2005, Gryfe_1998, Laken_1997, Leshno_2016, and Shtoyerman-Chen_2001), demonstrated that this variant is associated with a moderately increased risk for CRC in Ashkenazi Jewish population. A large meta-analysis concluded that the variant increases the risk about two-fold for CRC in individuals of Ashkenazi Jewish ancestry (OR=2.17, 95% CI=1.65-2.86), however it does not appear to confer an additional risk for CRC in non-Ashkenazi cases (Liang_2013). A recent case-control study involving a large Israeli cohort indicated that this variant might be also associated with a significantly higher risk for non-CRC cancers, with the APC I1307K variant being proposed as a reliable marker for overall cancer risk (OR=2.53) (Leshno_2016). The A8 mononucleotide tract created by this germline change has been shown to confer an increased propensity for generating somatic frameshift mutations on this allele, leading to a loss of function of APC that constitutes an important somatic event in tumor initiation (Gryfe_1998; Laken_1997). 19 other submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments, with 7 reporting it as a risk factor. Taken together, this polymorphic variant is associated with a modestly increased risk for CRC in the Ashkenazi Jewish population, but is not associated with FAP or AFAP. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.\"}"],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000266006","clinical_assertion_trait_set_id":"SCV000266006","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Shirts et al. (Genet Med 2016)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"506834.2016-03-03","interpretation_date_last_evaluated":"2015-11-20","version":"1","internal_id":"498299","clinical_assertion_observation_ids":["SCV000266006.0","SCV000266006.1","SCV000266006.2","SCV000266006.3","SCV000266006.4","SCV000266006.5","SCV000266006.6","SCV000266006.7","SCV000266006.8"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"1570","date_created":"2016-03-19","submitter_id":"506834","rcv_accession_id":"RCV000210085","submission_names":["GIM_BROCA"],"local_key":"c.3920T\u003eA","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Low penetrance mutation that is associated with a small increase in risk of colon cancer and with an increased risk of colon polyps (Boursi 2013)\"}"],"record_status":"current","interpretation_description":"risk factor","variation_id":"822"}
{"id":"SCV000591159","clinical_assertion_trait_set_id":"SCV000591159","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16140997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19047896\",\"@Source\":\"PubMed\"}}]},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","submission_id":"506152.2017-04-19","interpretation_date_last_evaluated":"2016-08-15","version":"1","internal_id":"1147603","clinical_assertion_observation_ids":["SCV000591159.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2017-08-25","submitter_id":"506152","rcv_accession_id":"RCV000120049","submission_names":["SHS20170111"],"local_key":"NM_000038.5:c.3920T\u003eA|not specified","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"822"}
{"id":"SCV000040392","clinical_assertion_trait_set_id":"SCV000040392","submission_id":"500062.2013-01-08","interpretation_date_last_evaluated":"2011-10-27","version":"1","internal_id":"40392","clinical_assertion_observation_ids":["SCV000040392.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000000822","review_status":"no assertion criteria provided","title":"NM_000038.3:c.3920T\u003eA and APC-Associated Polyposis Conditions","trait_set_id":"6265","date_created":"2011-05-06","submitter_id":"500062","rcv_accession_id":"RCV000020088","submission_names":[],"local_key":"NM_000038.3:c.3920T\u003eA_NBK1345","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\"}"],"record_status":"current","interpretation_description":"pathologic","variation_id":"822"}
{"id":"SCV000076444","clinical_assertion_trait_set_id":"SCV000076444","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500031.2020-02-06","interpretation_date_last_evaluated":"2020-01-19","version":"12","internal_id":"124374","clinical_assertion_observation_ids":["SCV000076444.0"],"date_last_updated":"2020-04-15","assertion_type":"variation to disease","variation_archive_id":"VCV000017674","review_status":"criteria provided, single submitter","trait_set_id":"7920","date_created":"2013-07-02","submitter_id":"500031","rcv_accession_id":"RCV000048431","submission_names":["SUB6933801"],"local_key":"306942|MedGen:C0677776","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Asn1355Lysfs*10) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80357508, ExAC 0.006%). This variant has been reported in multiple individuals and families affected with breast and ovarian cancer (PMID: 14757871, 8571953, 11802209, 21559243). This variant is also known as 4184del4 in the literature. ClinVar contains an entry for this variant (Variation ID: 17674). Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"17674"}
{"id":"SCV000788260","clinical_assertion_trait_set_id":"SCV000788260","content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21655256\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.arup.utah.edu/database/MEN2/MEN2_display.php\"}}]}}","submission_id":"506018.2018-05-10","interpretation_date_last_evaluated":"2018-05-04","version":"1","internal_id":"1538355","clinical_assertion_observation_ids":["SCV000788260.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000549768","review_status":"no assertion criteria provided","trait_set_id":"8702","date_created":"2018-07-27","submitter_id":"506018","rcv_accession_id":"RCV000664336","submission_names":["MEN2 update May 2018"],"local_key":"6|MedGen:CN073359","submitted_assembly":"not applicable","interpretation_comments":["{\"text\":\"The p.V292M/R67H/R982C allele was found in trans with p.C634Y in a Chinese family, genotype c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT]. One family member had both variant RET alleles and MTC onset at 13 yrs. Family members with only the p.C634Y mutation had MEN2A. Family members with the p.V292M/R67H/R982C allele had MTC (70 yr) and C-cell hyperplasia (44 yr). Variants p.R67H and p.R982C are common and likely benign, GnomAD frequency 0.1% and 2%, respectively (gnomad.broadinstitute.org/gene/ENSG00000165731). For reports of p.V292M alone, see c.874G\u003eA.\"}"],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"549768"}
